Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Winston

Showing results (301-310 of 343) with videos related to

Pageof 35
Sort By:
JAMA Internal Medicine|January 29, 2024
Using Behavioral Economics to Reduce Low-Value Care Among Older Adults: A Cluster Randomized Clinical TrialJeffrey T Kullgren, H Myra Kim, Megan Slowey, et al.
HIV Medicine|February 9, 2019
Depression, lifestyle factors and cognitive function in people living with HIV and comparable HIV-negative controlsD De Francesco, J Underwood, E Bagkeris, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 12, 2018
Defining a migrant-inclusive tuberculosis research agenda to end TBP B Shete, D Boccia, P Dhavan, et al.
Diagnostic Microbiology and Infectious Disease|March 25, 2016
Are current screening protocols for chronic hepatitis B virus infection adequate?Eva Mortensen, Amanda Kamali, Patricia L Schirmer, et al.
HIV Medicine|November 20, 2013
The effects of age on associations between markers of HIV progression and markers of metabolic function including albumin, haemoglobin and lipid concentrationsM Samuel, S Jose, A Winston, et al.
HIV Medicine|February 26, 2015
Factors associated with neurocognitive test performance at baseline: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trialE J Wright, B Grund, L A Cysique, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 13, 2009
Isoniazid, rifampin, ethambutol, and pyrazinamide pharmacokinetics and treatment outcomes among a predominantly HIV-infected cohort of adults with tuberculosis from BotswanaSekai Chideya, Carla A Winston, Charles A Peloquin, et al.
Journal of Viral Hepatitis|September 29, 2009
Does acute hepatitis C infection affect the central nervous system in HIV-1 infected individuals?A Winston, L Garvey, E Scotney, et al.
Kidney International|August 26, 2004
The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infectionLynda Anne Szczech, Samir K Gupta, Ramez Habash, et al.
Journal of the American Society of Nephrology : JASN|October 29, 2000
Renal epithelium is a previously unrecognized site of HIV-1 infectionLeslie A Bruggeman, Michael D Ross, Nozomu Tanji, et al.
Pageof 35

Showing results (301-310 of 343) with videos related to

Sort By:
Pageof 35
JAMA Internal Medicine|January 29, 2024
Using Behavioral Economics to Reduce Low-Value Care Among Older Adults: A Cluster Randomized Clinical TrialJeffrey T Kullgren, H Myra Kim, Megan Slowey, et al.
HIV Medicine|February 9, 2019
Depression, lifestyle factors and cognitive function in people living with HIV and comparable HIV-negative controlsD De Francesco, J Underwood, E Bagkeris, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 12, 2018
Defining a migrant-inclusive tuberculosis research agenda to end TBP B Shete, D Boccia, P Dhavan, et al.
Diagnostic Microbiology and Infectious Disease|March 25, 2016
Are current screening protocols for chronic hepatitis B virus infection adequate?Eva Mortensen, Amanda Kamali, Patricia L Schirmer, et al.
HIV Medicine|November 20, 2013
The effects of age on associations between markers of HIV progression and markers of metabolic function including albumin, haemoglobin and lipid concentrationsM Samuel, S Jose, A Winston, et al.
HIV Medicine|February 26, 2015
Factors associated with neurocognitive test performance at baseline: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trialE J Wright, B Grund, L A Cysique, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 13, 2009
Isoniazid, rifampin, ethambutol, and pyrazinamide pharmacokinetics and treatment outcomes among a predominantly HIV-infected cohort of adults with tuberculosis from BotswanaSekai Chideya, Carla A Winston, Charles A Peloquin, et al.
Journal of Viral Hepatitis|September 29, 2009
Does acute hepatitis C infection affect the central nervous system in HIV-1 infected individuals?A Winston, L Garvey, E Scotney, et al.
Kidney International|August 26, 2004
The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infectionLynda Anne Szczech, Samir K Gupta, Ramez Habash, et al.
Journal of the American Society of Nephrology : JASN|October 29, 2000
Renal epithelium is a previously unrecognized site of HIV-1 infectionLeslie A Bruggeman, Michael D Ross, Nozomu Tanji, et al.
Pageof 35